238 related articles for article (PubMed ID: 15282656)
1. Bivalirudin, blood loss, and graft patency in coronary artery bypass surgery.
Merry AF
Semin Thromb Hemost; 2004 Jun; 30(3):337-46. PubMed ID: 15282656
[TBL] [Abstract][Full Text] [Related]
2. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery.
Merry AF; Raudkivi PJ; Middleton NG; McDougall JM; Nand P; Mills BP; Webber BJ; Frampton CM; White HD
Ann Thorac Surg; 2004 Mar; 77(3):925-31; discussion 931. PubMed ID: 14992900
[TBL] [Abstract][Full Text] [Related]
3. Bivalirudin as alternative to both danaparoid and heparin in off-pump coronary artery bypass grafting.
Baciewicz FA
J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2108-9; author reply 2109. PubMed ID: 14688746
[No Abstract] [Full Text] [Related]
4. Routine use of the direct thrombin inhibitor bivalirudin for off-pump coronary artery bypass grafting is safe and effective.
Palmer GJ; Sankaran IS; Sparkman GM; Koster A; Dyke CM; Ebra G
Heart Surg Forum; 2008; 11(1):E24-9. PubMed ID: 18270134
[TBL] [Abstract][Full Text] [Related]
5. Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery.
McNair E; Marcoux JA; Bally C; Gamble J; Thomson D
Perfusion; 2016 Apr; 31(3):189-99. PubMed ID: 25934498
[TBL] [Abstract][Full Text] [Related]
6. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
[TBL] [Abstract][Full Text] [Related]
7. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
Gurbuz AT; Elliott WG; Zia AA
Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
[TBL] [Abstract][Full Text] [Related]
8. Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia.
Dyke CM; Koster A; Veale JJ; Maier GW; McNiff T; Levy JH
Ann Thorac Surg; 2005 Jul; 80(1):299-303. PubMed ID: 15975385
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study.
Smedira NG; Dyke CM; Koster A; Jurmann M; Bhatia DS; Hu T; McCarthy HL; Lincoff AM; Spiess BD; Aronson S
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):686-92. PubMed ID: 16515924
[TBL] [Abstract][Full Text] [Related]
10. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A
Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896
[TBL] [Abstract][Full Text] [Related]
11. Heparin versus danaparoid in off-pump coronary bypass grafting: results of a prospective randomized clinical trial.
Carrier M; Robitaille D; Perrault LP; Pellerin M; Pagé P; Cartier R; Bouchard D
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):325-9. PubMed ID: 12579101
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
Lepor NE
Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
[TBL] [Abstract][Full Text] [Related]
13. Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox
Hassen K; Maccaroni MR; Sabry H; Mukherjee S; Serumadar S; Birdi I
Perfusion; 2018 Apr; 33(3):235-240. PubMed ID: 28789610
[TBL] [Abstract][Full Text] [Related]
14. Bivalirudin utilization in cardiac surgery: shifting anticoagulation from indirect to direct thrombin inhibition.
Anand SX; Viles-Gonzalez JF; Mahboobi SK; Heerdt PM
Can J Anaesth; 2011 Mar; 58(3):296-311. PubMed ID: 21136312
[TBL] [Abstract][Full Text] [Related]
15. Bivalirudin in PCI: an overview of the REPLACE-2 trial.
Maroo A; Lincoff AM
Semin Thromb Hemost; 2004 Jun; 30(3):329-36. PubMed ID: 15282655
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia and its treatment.
Warkentin TE
J Thromb Thrombolysis; 2000 Jun; 9 Suppl 1():S29-35. PubMed ID: 10859582
[No Abstract] [Full Text] [Related]
17. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.
Koster A; Dyke CM; Aldea G; Smedira NG; McCarthy HL; Aronson S; Hetzer R; Avery E; Spiess B; Lincoff AM
Ann Thorac Surg; 2007 Feb; 83(2):572-7. PubMed ID: 17257990
[TBL] [Abstract][Full Text] [Related]
18. Role of Bivalirudin for Anticoagulation in Adult Perioperative Cardiothoracic Practice.
Erdoes G; Ortmann E; Martinez Lopez De Arroyabe B; Reid C; Koster A
J Cardiothorac Vasc Anesth; 2020 Aug; 34(8):2207-2214. PubMed ID: 31521492
[TBL] [Abstract][Full Text] [Related]
19. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.
Mahaffey KW; Lewis BE; Wildermann NM; Berkowitz SD; Oliverio RM; Turco MA; Shalev Y; Ver Lee P; Traverse JH; Rodriguez AR; Ohman EM; Harrington RA; Califf RM;
J Invasive Cardiol; 2003 Nov; 15(11):611-6. PubMed ID: 14608128
[TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid.
Kanagasabay R; Unsworth-White MJ; Farnsworth G; Haxby EJ; Smith EE
J Thorac Cardiovasc Surg; 2000 Aug; 120(2):428-9. PubMed ID: 10917979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
